Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC4186 in stable heart failure with impaired glucose tolerance or type 2 diabetes
2008-006237-27Phase 2Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of TRC4186 in heart failure (HF), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Primary efficacy and Safety and recommended dose. Started Jul 2009; status: completed.
02
Drugs
TRC4186
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-006237-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006237-27.